A mechanistic rationale for the investigation of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction. Letter regarding the article 'Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial'

doi:10.1002/ejhf.2091

Comment

. 2021 May;23(5):841.

doi: 10.1002/ejhf.2091. Epub 2021 Feb 4.

A mechanistic rationale for the investigation of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction. Letter regarding the article 'Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial'

Steffen Pabel¹, Nazha Hamdani², Samuel Sossalla^{1

3}

Affiliations

¹ Department of Internal Medicine II, University Medical Centre Regensburg, Regensburg, Germany.
² Department of Molecular and Experimental Cardiology, Ruhr University Bochum, Bochum, Germany.
³ Clinic for Cardiology and Pneumology, Georg-August University Göttingen and DZHK (German Centre for Cardiovascular Research), partner site Göttingen, Göttingen, Germany.

PMID: 33377246
DOI: 10.1002/ejhf.2091

Free article

Comment

A mechanistic rationale for the investigation of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction. Letter regarding the article 'Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial'

Steffen Pabel et al. Eur J Heart Fail. 2021 May.

Free article

. 2021 May;23(5):841.

doi: 10.1002/ejhf.2091. Epub 2021 Feb 4.

Authors

Steffen Pabel¹, Nazha Hamdani², Samuel Sossalla^{1

3}

Affiliations

¹ Department of Internal Medicine II, University Medical Centre Regensburg, Regensburg, Germany.
² Department of Molecular and Experimental Cardiology, Ruhr University Bochum, Bochum, Germany.
³ Clinic for Cardiology and Pneumology, Georg-August University Göttingen and DZHK (German Centre for Cardiovascular Research), partner site Göttingen, Göttingen, Germany.

PMID: 33377246
DOI: 10.1002/ejhf.2091

No abstract available

PubMed Disclaimer

Comment on

Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial.
Anker SD, Butler J, Filippatos GS, Jamal W, Salsali A, Schnee J, Kimura K, Zeller C, George J, Brueckmann M, Zannad F, Packer M; EMPEROR-Preserved Trial Committees and Investigators. Anker SD, et al. Eur J Heart Fail. 2019 Oct;21(10):1279-1287. doi: 10.1002/ejhf.1596. Epub 2019 Sep 16. Eur J Heart Fail. 2019. PMID: 31523904
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial.
Anker SD, Butler J, Filippatos G, Shahzeb Khan M, Ferreira JP, Bocchi E, Böhm M, Brunner-La Rocca HP, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, Gonzalez-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Piña IL, Ponikowski P, Senni M, Seronde MF, Sim D, Spinar J, Squire I, Taddei S, Tsutsui H, Verma S, Vinereanu D, Zhang J, Jamal W, Schnaidt S, Schnee JM, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Preserved Trial Committees and Investigators. Anker SD, et al. Eur J Heart Fail. 2020 Dec;22(12):2383-2392. doi: 10.1002/ejhf.2064. Eur J Heart Fail. 2020. PMID: 33251670 Clinical Trial.

Cited by

SGLT2 Inhibitors and Their Mode of Action in Heart Failure-Has the Mystery Been Unravelled?
Pabel S, Hamdani N, Luedde M, Sossalla S. Pabel S, et al. Curr Heart Fail Rep. 2021 Oct;18(5):315-328. doi: 10.1007/s11897-021-00529-8. Epub 2021 Sep 15. Curr Heart Fail Rep. 2021. PMID: 34523061 Free PMC article. Review.
Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction.
Pabel S, Hamdani N, Singh J, Sossalla S. Pabel S, et al. Front Physiol. 2021 Nov 5;12:752370. doi: 10.3389/fphys.2021.752370. eCollection 2021. Front Physiol. 2021. PMID: 34803735 Free PMC article. Review.
SGLT2-Inhibitors on HFpEF Patients. Role of Ejection Fraction.
Requena-Ibanez JA, Santos-Gallego CG, Zafar MU, Badimon JJ. Requena-Ibanez JA, et al. Cardiovasc Drugs Ther. 2023 Oct;37(5):989-996. doi: 10.1007/s10557-022-07371-7. Epub 2022 Aug 3. Cardiovasc Drugs Ther. 2023. PMID: 35920946 Review.
Disparities in Postdischarge Ambulatory Care Follow-Up Among Medicaid Beneficiaries With Diabetes, Hospitalized for Heart Failure.
Khodneva Y, Levitan EB, Arora P, Presley CA, Oparil S, Cherrington AL. Khodneva Y, et al. J Am Heart Assoc. 2023 Jun 20;12(12):e029094. doi: 10.1161/JAHA.122.029094. Epub 2023 Jun 7. J Am Heart Assoc. 2023. PMID: 37284763 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A mechanistic rationale for the investigation of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction. Letter regarding the article 'Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial'

Affiliations

A mechanistic rationale for the investigation of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction. Letter regarding the article 'Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial'

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical